When Eoptolink Technology Inc.,Ltd. (SHE: 300502) released its half-year report on the evening of August 24, it showed revenue doubling and net profit reaching 7.529 billion yuan. Yet the market responded with a cold shower the next day, as the stock fell over 2%.
The market's reaction is justified. The real takeaway from this report is not about "how much it grew," but that "the quality of that growth is shrinking." The doubling of revenue is genuine, but profits are increasingly disconnected from actual cash flow, and growth is increasingly dependent on volume over price. That 6.79% decline is the market beginning to re-evaluate the company using "quality" as its yardstick.
A Half-Year Report Now Large Enough to Attract Scrutiny
First, let's characterize this report: it is no longer one that needs to prove itself, but rather one so strong that it invites nitpicking. At this scale, market expectations have shifted from "can it grow?" to "is the growth clean?"
For the first half, operating revenue reached 20.910 billion yuan, a year-on-year increase of 100.34%, while net profit attributable to shareholders was 7.529 billion yuan, up 90.98%. Deducted non-recurring net profit was 7.511 billion yuan, nearly identical to the reported net profit—this 7.5 billion is genuinely earned from core operations, not propped up by one-time gains.
The growth engine is the optical module business. Optical interconnect products, accounting for 99.87% of revenue, sold 20.883 billion yuan in the first half, doubling year-on-year, with a gross margin of 48.46%. Production capacity expanded from 15.2 million units in the same period last year to 28.36 million units, with both production output and sales volume increasing by 50% to 60%. Orders from AI data centers are genuinely flowing into the factories.
But as the scale grows, two structural issues become more glaring. First, overseas revenue of 20.460 billion yuan accounts for 97.92% of total revenue, meaning nearly all bets are placed on foreign markets. Second, R&D investment of 440 million yuan represents only 2.1% of revenue. One determines the risk exposure, the other determines the depth of the moat—both will be elaborated on later.
The Most Glaring Crack Lies Between Profit and Cash
The most concerning figure in this report is not any growth number, but a widening chasm: the gap between profits earned and cash actually received exceeds twofold.
Net cash flow from operating activities in the first half was only 1.616 billion yuan, while net profit for the same period was 7.529 billion yuan. For every 100 yuan of profit earned, only a little over 20 yuan actually returns as cash. For context, the full-year 2025 cash conversion rate was around 80%—it has collapsed within half a year.
The cash is tied up in two places. Inventories of 11.655 billion yuan reflect proactive stockpiling for hand-on orders and lead times; accounts receivable turnover is only 1.92 times, as overseas major customers pay slowly, with revenue recognized upfront and cash collection lagging behind.
To be fair, operating cash flow still grew 69.67% year-on-year, so the direction is correct. But the quality of profit is undeniably compromised. For a company with doubling profits but cash growing only 70%, the true quality of that growth warrants questioning.
The Short-Term Peak in Gross Margin Was Last Quarter
Gross margin is the most deceptive figure in this report: year-over-year, it is still rising; quarter-over-quarter, it has already peaked.
Optical interconnect product gross margin was 48.46%, up 0.99 percentage points from the same period last year—the highlight repeatedly emphasized in the report. But breaking it down by quarter, second-quarter sales gross margin was 47.96%, down nearly one percentage point from 48.91% in last year's fourth quarter. The short-term peak likely occurred in the fourth quarter of last year.
The decline stems from the ramp-up of 1.6T products. During early mass production of higher-specification optical modules, yields are low and costs are high, compounded by pricing pressure from major customers, squeezing gross margins from both ends. This is a normal stage of product iteration and not bad news in itself.
However, the signal it sends is clear: the phase where Eoptolink could rely on product upgrades to lift margins is nearing its end. Going forward, every new product launch will become a trade-off between "revenue growth" and "margin dilution."
A 2.1% R&D Ratio: A Ticket That May Be Expiring
The 2.1% R&D ratio is the most vulnerable number for a company of this scale—and the hardest to defend.
First-half R&D investment was 440 million yuan, up 31.85% year-on-year, with 17 new authorized invention patents. The growth rate is not slow, but as a percentage of revenue, it stands at just 2.1%, which is thin by technology industry standards.
The company could argue that optical modules are a manufacturing-heavy, process-intensive business where the moat lies in engineering mass production and yield control, not in piling up engineers. That defense holds, but only half—process advantages can defend mid- and low-speed rates, but not the generational leap to higher speeds.
The report shows the company has laid out plans in silicon photonics, thin-film lithium niobate, coherent optics, and 800G LPO. The problem is that each of these directions requires substantial capital investment. Whether a 2.1% R&D ratio can sustain leadership in 1.6T and beyond remains unanswered, and the answer depends on how fast competitors catch up.
Among the Big Three, Sliding Toward Follower Status?
When placing Eoptolink back into the "big three" of the optical module sector, its position is more delicate than the report suggests. It is shifting from being a co-leader to becoming a follower.
Innoscience Technology reported first-half revenue of 41.778 billion yuan, up 182.49% year-on-year, with net profit of 13.651 billion yuan, up 241.7%. That's twice Eoptolink's revenue, with even faster growth. TFC Communication reported revenue of 2.828 billion yuan, up 15.15%, and net profit of 1.204 billion yuan, up 33.92%, holding its position through high margins in passive components.
Eoptolink sits in the middle—without Innoscience's scale, nor TFC's gross margin moat. In the same AI boom, the three companies are running at three different speeds, with Eoptolink in second gear, and the gap to the leader widening.
The more critical gap is in 1.6T. Innoscience explicitly disclosed that its 1.6T silicon photonics modules have entered volume ramp-up with shipments rising quarter over quarter. Eoptolink only mentioned that second-quarter shipments grew from the first quarter, with a more restrained ramp-up pace. Innoscience also announced a dividend of over 14 billion yuan this time, while Eoptolink is retaining all earnings for capacity expansion. One can already expand capacity and pay dividends simultaneously; the other is still catching up with full effort.
1.6T Is the Only Opportunity and the Biggest Gamble
Eoptolink's next chapter can be summarized in one sentence: 1.6T is its only chance to catch up with the top tier, and it is a bet that puts both cash and margins on the line.
The half-year report shows that 800G is now the main shipping product, with 1.6T second-quarter shipments significantly increasing from the first quarter, and the ramp-up pace accelerating from the second half onward. Overseas capacity in Thailand and other locations is also being ramped up, with total guarantee limits for Thai and Singapore subsidiaries reaching 4.2 billion yuan. Previous institutional communications indicated high order visibility for Q3, Q4, and 2027.
If the bet pays off, the revenue ceiling will open again, and scale-driven cost dilution could even feed back into gross margins. If the bet fails, or the ramp-up pace lags Innoscience, the 11.655 billion yuan in inventory and continuously expanding capacity will transform from "growth fuel" into an "inventory burden."
This is a classic second-order problem. The market is willing to pay for growth, but not for diluted growth. What Eoptolink must prove is that it can maintain profit quality while scaling volume—and that is precisely where it performed least convincingly in the first half.
In this half-year report, the speed of growth is impeccable, but the quality of growth is falling behind. Three variables will determine its performance in the second half: whether operating cash flow can catch up with profit, whether gross margin can stabilize after 1.6T ramps up, and whether a 2.1% R&D ratio can sustain its generational lead. That 6.79% decline is not the end—it is the starting point where the market begins re-measuring Eoptolink with the "quality" yardstick. The verdict will come at the end of Q3.
Comments